Exponential Growth Expected for Antibody-drug Conjugates (ADCs) – CDMOs Continue to Play a Major Role in Manufacturing and Co-Development

CHANDLER, Ariz., Nov. 13, 2018 /PRNewswire-PRWeb/ — A survey by the publishers of ADC Review | Journal of Antibody-drug Conjugates showed that in 2017 the global market for antibody therapies reached U.S. $ 4 billion. Approximately forty-five percent of this market included Antibody-drug Conjugates (ADCs). However, in the next few years the market for novel antibody therapies (including ADCs) is expected to grow significantly, to U.S. $ 17 billion by 2023. [1][2][3] In addition to this exponential growth, the survey also confirmed an ongoing trend of outsourcing manufacturing and/or co-development to integrated Contract Development Manufacturing Organizations (CDMOs). As a result, the ...

Gepostet in der Kategorie Wirtschaft (Anzahl der ansichten:) 8

Ähnlich Nachrichten